Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers' work from University of Sherbrooke focuses on immunization
November 12th, 2008
According to recent research from Sherbrooke, Canada, "Based on promising results from laboratory studies, we hypothesized that pneumococcal vaccination would protect patients from myocardial infarction. We conducted a hospital-based case-control study that included patients considered to be at risk of myocardial infarction." "We used health databases to obtain hospital diagnoses and vaccination status. We compared patients who had been admitted for treatment of myocardial infarction with patients admitted to a surgical department in the same hospital for a reason other than myocardial infarction between 1997 and 2003. We found a total of 43 209 patients who were at...
Source: Vaccine Weekly (2008-11-12)
|
